Home » Topics » BioWorld Science

BioWorld Science
RSS

New NLRP3 inflammasome inhibitors identified at NodThera

March 31, 2022

New STAT5 inhibitors synthesized at Janpix

March 31, 2022

The University of Southern California patents Huntingtin aggregation inhibitors

March 31, 2022

Orexia Therapeutics discovers orexin OX2 receptor agonists

March 31, 2022

New STING agonists identified at The Scripps Research Institute

March 31, 2022

Adenosine A2B receptor targeting protects against acetaminophen-induced hepatotoxicity

March 31, 2022

Researchers present new Slc39a14-knockout dystonia murine model

March 30, 2022

Protein is marker, target for diabetic neuropathy

March 30, 2022

Alpha Cognition reports in vivo and in vitro data on ALPHA-0602 for ALS

March 30, 2022

Novel ferroptosis inhibitor mitigates cerebral ischemic injury in rat

March 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...